Sedana Medical AB (publ) (STO: SEDANA)

Market Cap	2.32B
Revenue (ttm)	168.68M
Net Income (ttm)	-41.47M
Shares Out	99.34M
EPS (ttm)	-0.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,178
Open	23.05
Previous Close	23.05
Day's Range	22.80 - 23.60
52-Week Range	13.88 - 28.60
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 79
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2023, Cint Group AB's revenue was 266.54 million, a decrease of -9.71% compared to the previous year's 295.19 million. Losses were -448.21 million, 27.0% more than in 2022.